Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$22.28 - $38.71 $75,907 - $131,884
-3,407 Reduced 1.67%
200,363 $6.15 Million
Q3 2022

Nov 09, 2022

BUY
$34.2 - $51.69 $3.18 Million - $4.81 Million
92,973 Added 83.91%
203,770 $6.97 Million
Q2 2022

Aug 10, 2022

SELL
$23.14 - $49.68 $111,511 - $239,407
-4,819 Reduced 4.17%
110,797 $3.84 Million
Q1 2022

May 04, 2022

SELL
$27.77 - $64.4 $173,979 - $403,466
-6,265 Reduced 5.14%
115,616 $5.09 Million
Q4 2021

Feb 10, 2022

SELL
$54.9 - $105.21 $318,420 - $610,218
-5,800 Reduced 4.54%
121,881 $7.66 Million
Q3 2021

Nov 10, 2021

SELL
$105.0 - $178.37 $238,350 - $404,899
-2,270 Reduced 1.75%
127,681 $13.5 Million
Q2 2021

Aug 13, 2021

SELL
$125.11 - $180.0 $2.62 Million - $3.77 Million
-20,933 Reduced 13.87%
129,951 $23 Million
Q1 2021

May 14, 2021

SELL
$126.27 - $191.71 $886,541 - $1.35 Million
-7,021 Reduced 4.45%
150,884 $20.1 Million
Q4 2020

Feb 02, 2021

SELL
$81.94 - $135.34 $31,383 - $51,835
-383 Reduced 0.24%
157,905 $21.4 Million
Q3 2020

Nov 05, 2020

BUY
$73.3 - $89.48 $1.56 Million - $1.91 Million
21,347 Added 15.59%
158,288 $13.2 Million
Q2 2020

Aug 12, 2020

BUY
$48.82 - $82.53 $2.8 Million - $4.74 Million
57,395 Added 72.15%
136,941 $11.2 Million
Q1 2020

May 12, 2020

BUY
$39.1 - $62.9 $45,043 - $72,460
1,152 Added 1.47%
79,546 $4.1 Million
Q4 2019

Jan 27, 2020

BUY
$29.79 - $43.06 $61,307 - $88,617
2,058 Added 2.7%
78,394 $3.26 Million
Q3 2019

Oct 31, 2019

BUY
$30.47 - $37.65 $1.06 Million - $1.31 Million
34,700 Added 83.34%
76,336 $2.47 Million
Q2 2019

Aug 15, 2019

BUY
$25.73 - $35.79 $191,251 - $266,027
7,433 Added 21.73%
41,636 $1.45 Million
Q1 2019

May 03, 2019

BUY
$21.71 - $31.54 $41,900 - $60,872
1,930 Added 5.98%
34,203 $1.01 Million
Q4 2018

Feb 08, 2019

BUY
$14.95 - $24.72 $65,361 - $108,075
4,372 Added 15.67%
32,273 $749,000
Q3 2018

Nov 13, 2018

BUY
$17.8 - $25.35 $496,637 - $707,290
27,901 New
27,901 $544,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.